Insulet Corporation (PODD) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Insulet financial statements at a glance

Insulet reported revenue of $2.71 billion for fiscal year 2025 (ended December 31, 2025), up 30.7% from fiscal year 2024. Net income was $247.10 million, a net margin of 9.1%.

At the end of fiscal year 2025 it had total assets of $3.19 billion and shareholders' equity of $1.52 billion, with cash and short-term investments of $716.10 million and total debt of $949.20 million.

Its operations brought in $569.30 million of cash; capital spending was $219.40 million, leaving free cash flow of $349.90 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

PODD logo

Insulet Corporation

PODDUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
2.71B
Prev Year: 2.07B
YoY: +30.7%
Operating Revenue
2.71B
Prev Year: 2.07B
YoY: +30.7%
Tax Effect of Unusual Items
-30.32M
Interest Income
34.70M
Prev Year: 39.50M
YoY: -12.2%
Average Dilution Earnings
3.00M
Gain on Sale of Securities
12.50M
Non-operating Interest Income
34.70M
Prev Year: 39.50M
YoY: -12.2%
Cost of Revenue
768.20M
Prev Year: 625.90M
YoY: +22.7%
Gross Profit
1.94B
Prev Year: 1.45B
YoY: +34.2%
Operating Expense
1.47B
Prev Year: 1.14B
YoY: +29.0%
Selling General and Administrative
1.17B
Prev Year: 917.20M
YoY: +27.0%
Research and Development
301.10M
Prev Year: 219.60M
YoY: +37.1%
Operating Income
473.80M
Prev Year: 308.90M
YoY: +53.4%
Net Non Operating Interest Income Expense
-24.70M
Prev Year: -3.20M
YoY: -671.9%
Non-operating Interest Expense
59.40M
Prev Year: 42.70M
YoY: +39.1%
Other Income Expense
-109.60M
Prev Year: -5.50M
YoY: -1892.7%
Special Income Charges
-123.90M
Other Special Charges
123.90M
Other Non-operating Income (expense)
1.80M
Prev Year: -5.50M
YoY: +132.7%
Pre-tax Income
339.50M
Prev Year: 300.20M
YoY: +13.1%
Provision for Income Taxes
92.40M
Prev Year: -118.10M
YoY: +178.2%
Net Income Common Stockholders
247.10M
Prev Year: 418.30M
YoY: -40.9%
Net Income
247.10M
Prev Year: 418.30M
YoY: -40.9%
Net Income Including Non-Controlling Interests
247.10M
Prev Year: 418.30M
YoY: -40.9%
Net Income from Continuing Operations
247.10M
Prev Year: 418.30M
YoY: -40.9%
Diluted NI Available to Com Stockholders
250.10M
Prev Year: 418.30M
YoY: -40.2%
Total Operating Income as Reported
473.80M
Prev Year: 308.90M
YoY: +53.4%
Basic EPS
-
Prev Year: 5.97
Total Expenses
2.23B
Prev Year: 1.76B
YoY: +26.8%
Diluted EPS
-
Prev Year: 5.78
Net Income from Continuing and Discontinued Operation
247.10M
Prev Year: 418.30M
YoY: -40.9%
Weighted Average Shares (basic)
-
Prev Year: 70.08M
Normalized Income
328.18M
Prev Year: 418.30M
YoY: -21.5%
Weighted Average Shares (diluted)
-
Prev Year: 73.89M
Interest Expense
59.40M
Prev Year: 42.70M
YoY: +39.1%
Net Interest Income
-24.70M
Prev Year: -3.20M
YoY: -671.9%
EBIT
398.90M
Prev Year: 342.90M
YoY: +16.3%
EBITDA
489.30M
Prev Year: 423.70M
YoY: +15.5%
Reconciled Cost of Revenue
768.20M
Prev Year: 625.90M
YoY: +22.7%
Reconciled Depreciation
90.40M
Prev Year: 80.80M
YoY: +11.9%
Net Income from Continuing Operation Net Minority Interest
247.10M
Prev Year: 418.30M
YoY: -40.9%
Total Unusual Items Excluding Goodwill
-111.40M
Total Unusual Items
-111.40M
Normalized EBITDA
600.70M
Prev Year: 423.70M
YoY: +41.8%
Tax Rate for Calcs
0.272
Prev Year: 0
Values in USD

Insulet key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$2.7B$2.1B$1.7B$1.3B$1.1B
Gross profit$1.9B$1.4B$1.2B$805.6M$752.1M
Operating income$473.8M$308.9M$220.0M$37.6M$126.0M
Net income$247.1M$418.3M$206.3M$4.6M$16.8M
Diluted EPS–$5.78$2.94$0.07$0.24
Total assets$3.2B$3.1B$2.6B$2.3B$2.0B
Total liabilities–$1.9B$1.9B$1.8B$1.5B
Shareholders' equity$1.5B$1.2B$732.7M$476.4M$556.3M
Cash and short-term investments$716.1M$953.4M$704.2M$674.2M$790.0M
Total debt$949.2M$1.4B$1.4B$1.4B$1.3B
Operating cash flow$569.3M$430.3M$145.7M$119.0M-$68.1M
Capital spending$219.4M$134.0M$109.2M$157.3M$122.7M
Free cash flow$349.9M$296.3M$36.5M-$38.3M-$190.8M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was Insulet's revenue in fiscal year 2025?

$2.71 billion, up 30.7% from $2.07 billion in fiscal year 2024.

How much profit does Insulet make?

Insulet reported net income of $247.10 million for fiscal year 2025 (9.1% of revenue); operating income was $473.80 million.

How much cash and debt does Insulet have?

At the end of fiscal year 2025: cash and short-term investments of $716.10 million and total debt of $949.20 million.

What is Insulet's free cash flow?

$349.90 million in fiscal year 2025 (operating cash flow of $569.30 million minus capital spending of $219.40 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube